Dr. Sarah Mohiuddin of C.S. Mott Children’s Hospital is addressing misconceptions about autism after a recent debate linked Tylenol use during pregnancy to the condition. She emphasizes that genetics, not parental choices or medications, is the primary factor. Her team is launching a national curriculum, TEAM, to train health providers in autism care and highlight emerging research, including experimental treatments, while U-M researchers continue advancing genetic and clinical studies to better understand autism. Continue reading here.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.